PathShodh - The Health-care start-up from CeNSE
Driven by a social mission of making healthcare diagnosis affordable and available to all, PathShodh Healthcare Pvt. Ltd. is built on a very strong foundation of innovative research conducted at the Centre for Nano Science and Engineering, IISc. Born out of the research conducted by Prof. Navakanta Bhat and his student Mr. Vinay Kumar at CeNSE, PathShodh is a medical device research and development company incubated at the Indian Institute of Science (IISc), Bangalore. With a comprehensive IP portfolio (1 issued US patent and 5 more international patents filed), PathShodh has developed first of its kind handheld device for managing Diabetes and its complications.
The devices developed go far beyond the conventional glucometers, and enable point of care testing of 8 bio markers on a single device. This is the only device in the world which can perform Glucose, HbA1c and Glycated Albumin tests for efficient glycaemic control; Serum Albumin and Haemoglobin tests for malnutrition index and liver disease; Microalbuminuria, Urine Creatinine and Albumin to Creatinine Ratio tests for Diabetic Nephropathy. The pre-clinical validation of the device has been already completed by the company, with blood and urine samples. After a comprehensive clinical validation, the company aims to launch the product in the market during third/fourth quarter of 2016.
For more details, please visit the website link: www.pathshodh.com
